NCT04385498

Brief Summary

Mixed methods (qualitative and quantitative) cluster randomized pilot feasibility trial (n=40) to refine the the Brief Relaxation, Education and Trauma Healing (BREATHE) Ethiopia intervention and explore effectiveness and implementation. Fifty patients will be enrolled across the pre-pilot and the pilot to account for potential treatment dropout. Eight health care centers will be randomized to Treatment or Waitlist conditions.

  1. 1.Primary outcomes: Change in hypothesized treatment mechanisms: (1) increased knowledge about PTSD; reductions in (2) PTSD-related stigma; (3) trauma-related cognitions; and (4) self-reported arousal; (5) increased use of stress management strategies; and (6) reductions in physiological arousal as measured by increased heart rate variability.
  2. 2.Secondary outcomes: Change in symptoms and functional impairment. Reductions in (1) PTSD (2) depression and anxiety symptoms, and (3) functional impairment.
  3. 3.Process evaluation: Mixed methods multi-stakeholder process evaluation of the implementation of the intervention as measured by the RE-AIM framework (Reach, Effectiveness, Adoption, Implementation, Maintenance). We will collect qualitative data on Adoption and Implementation (e.g. facilitators and barriers to intervention delivery) and quantitative assessment of patient and provider participation and retention (Reach), satisfaction (Adoption) and fidelity (Implementation).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 28, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

May 13, 2020

Completed
3.1 years until next milestone

Study Start

First participant enrolled

June 1, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

August 6, 2025

Status Verified

August 1, 2025

Enrollment Period

5 months

First QC Date

April 28, 2020

Last Update Submit

August 1, 2025

Conditions

Keywords

Post Traumatic Stress DisorderSevere Mental Illnesspsychotherapyglobal mental healthEthiopia

Outcome Measures

Primary Outcomes (6)

  • Change in PTSD Knowledge

    Changes in levels of PTSD Knowledge measured by the PTSD Knowledge Test (0-14, higher scores indicating more PTSD knowledge).

    Day 0 baseline, 3 months

  • Change in PTSD Related Stigma

    Changes in levels of PTSD Related Stigma measured by The Internalized Stigma of Mental Illness Scale (1 minimal stigma to 4 severe internalized stigma).

    Day 0 baseline, 3 months

  • Change in Trauma-related cognitions

    Changes in levels of trauma-related cognitions assessed by the Post-Traumatic Cognitions Inventory (36-252 higher scores indicating higher incidence of negative trauma related cognitions).

    Day 0 baseline, 3 months

  • Change in Self-reported arousal

    Changes in self-reported arousal levels measured with Self-Assessment Manikin (Self-Assessment Manikin measures arousal using 3 subscales: Valence, 1 unpleasant to 5 pleasant; Arousal rating, 1 calm to 5 excited; and Dominance, 1 independent to 5 dependent).

    Day 0 baseline, 3 months

  • Change in Stress management strategy use

    Changes in use of the breathing retraining techniques as measured by self- and caregiver-reports during in-session homework review.

    Day 0 baseline, 3 months

  • Change in Physiological arousal

    Changes in physiological arousal levels measured by heart rate variability (HRV).

    Day 0 baseline, 3 months

Secondary Outcomes (4)

  • Change in PTSD Symptoms

    Day 0 baseline, 3 months

  • Change in Depression Symptoms

    Day 0 baseline, 3 months

  • Change in Anxiety Symptoms

    Day 0 baseline, 3 months

  • Change in Functional impairment

    Day 0 baseline, 3 months

Study Arms (2)

BREATHE Intervention

EXPERIMENTAL

Five session program, with additional sessions provided based on the individual's learning style and needs. Sessions are designed to be 20 to 30 minutes long, to accommodate the needs of the primary health care centers. Sessions will ideally be conducted once per week, but may be conducted as infrequently as once per month.

Behavioral: BREATHE Intervention

Waitlist Treatment as Usual

ACTIVE COMPARATOR

Typical primary care treatment which will include medication management and follow-up at the health facilities, at at least the same frequency as treatment arm. At the End of the trial participants will be able to receive the BREATHE Ethiopia PTSD treatment

Behavioral: Waitlist Treatment as Usual

Interventions

5 session program focusing on breathing retraining, psychoeducation, and positive coping.

Also known as: BREATHE Ethiopia
BREATHE Intervention

Typical primary care treatment which will include medication management and follow-up at the health facilities, at at least the same frequency as treatment arm. At the end of the trial Participants will be able to receive the BREATHE Ethiopia treatment.

Waitlist Treatment as Usual

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For all participants: Being 18 years of age or older
  • For all participants: Being able and willing to provide informed consent to participate in the study
  • For all participants: Being able to complete procedures in Amharic or English.
  • For patients: Treatment at a Sodo district primary care clinic for Severe Mental Illness (SMI)
  • For patients: Identified as having:
  • Experienced a traumatic event,
  • Associated PTSD symptoms defined as scores on the PTSD Checklist DSM-5 (PCL-5), AND
  • any associated functional impairment on the WHODAS-2.
  • For health care providers: Providers working at the target health centers who administer, provider care for, or supervise the care of patients with mental health concerns.
  • For caregivers: Being identified by the patient as a close family member or friend whom the patient gives permission to be involved in the study

You may not qualify if:

  • Current high risk of suicide as measured by the Composite International Diagnostic Interview (CIDI) Suicide module
  • Inability to participate in the treatment, as determined by the psychiatric nurse.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Addis Ababa University

Addis Ababa, Ethiopia

Location

Related Publications (1)

  • Ng LC, Serba EG, Dubale BW, Fekadu A, Hanlon C. Posttraumatic stress disorder intervention for people with severe mental illness in a low-income country primary care setting: a randomized feasibility trial protocol. Pilot Feasibility Stud. 2021 Jul 30;7(1):149. doi: 10.1186/s40814-021-00883-3.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticMental Disorders

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 28, 2020

First Posted

May 13, 2020

Study Start

June 1, 2023

Primary Completion

October 20, 2023

Study Completion

October 20, 2023

Last Updated

August 6, 2025

Record last verified: 2025-08

Locations